Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

New company Lattice Biotech advances biofilm disruption technology

March 16, 2015

FDA accepts resubmitted NDA for daclatasvir

March 13, 2015

Toyama Chemical reports development of antifungal agents

March 13, 2015

CureVac patents new rabies vaccine

March 13, 2015

Phase I results reported on novel peptide deformylase inhibitor, IDP-73152 mesylate

March 13, 2015

Phase II trial of TKM-Ebola-Guinea starts in Sierra Leone

March 12, 2015

Rotavac vaccine launched in India

March 12, 2015

CureVac patent describes antiviral combination vaccines

March 12, 2015

Novel HPV vaccine increases seroconversion levels after each vaccination

March 11, 2015

ContraVir Pharmaceuticals to begin pivotal phase III study of FV-100

March 10, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...